August 1979Incorporated as a private limited company in Koganei-shi, Tokyo
May 1983Constructed Tochigi Plant
July 1985Aquired manufacturing approval of MYCELL® HBsAg, the first diagnostic reagent product of our company
May 1986Head office moved to Koraku, Bunkyo-ku, Tokyo（Current address）
March 2002Contributed to the establishment of EpiPhoenix Co., Ltd.（presently PhoenixBio Co., Ltd.), a University of Hiroshima-based venture specializing in chimeric mice
October 2013Absorbed BioMedics Japan Inc.
April 2014Acquired Utsunomiya Office from Phoenix Bio Co., Ltd. Due to corporate division.
April 2015Acquired of patent licensing right of CRISPR/Cas9 system from Broad Institute. Acquired of patent licensing right to establish iPS cell and gene recombination from iPS Academia Japan.
